Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cutaneous Side Effects of New Antitumor Drugs
Ralf Gutzmer, Andreas Wollenberg, Selma Ugurel, et al.
Deutsches Ärzteblatt international (2012)
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The risk of rash associated with ipilimumab in patients with cancer: A systematic review of the literature and meta-analysis
Kira Minkis, Benjamin C. Garden, Shenhong Wu, et al.
Journal of the American Academy of Dermatology (2013) Vol. 69, Iss. 3, pp. e121-e128
Closed Access | Times Cited: 135
Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
Kumutnart Chanprapaph, Vasanop Vachiramon, Ploysyne Rattanakaemakorn
Dermatology Research and Practice (2014) Vol. 2014, pp. 1-8
Open Access | Times Cited: 96
Cutaneous adverse events caused by immune checkpoint inhibitors
Henry T. Quach, Douglas B. Johnson, Nicole R. LeBoeuf, et al.
Journal of the American Academy of Dermatology (2021) Vol. 85, Iss. 4, pp. 956-966
Closed Access | Times Cited: 90
Safety and Tolerability of Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors in Oncology
Rashmi R. Shah, Devron R. Shah
Drug Safety (2019) Vol. 42, Iss. 2, pp. 181-198
Closed Access | Times Cited: 76
Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors
Saveria Pastore, Daniela Lulli, Giampiero Girolomoni
Archives of Toxicology (2014) Vol. 88, Iss. 6, pp. 1189-1203
Closed Access | Times Cited: 66
New Oral Anti-Cancer Drugs and Medication Safety
Katja Schlichtig, Pauline Dürr, Frank Dörje, et al.
Deutsches Ärzteblatt international (2019)
Open Access | Times Cited: 46
Prevalent Types of Peristomal Skin Damage During Chemoradiotherapy and Their Risk Factors
Yi Chen, Yan Lu, Lijuan Zhang, et al.
Advances in Wound Care (2025)
Closed Access
Enhanced Tacrolimus Efficacy in Psoriasis with Innovative Transethosomes: A Promising Preclinical Study on Wistar Rats.
Vishwanath A Jadhav, Kishori P. Sutar, Sankalp S. Sammasagi, et al.
Drug Development and Industrial Pharmacy (2025), pp. 1-21
Closed Access
Mechanism of Lethal Skin Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors and Related Treatment Strategies
Yanping Li, Ruoqiu Fu, Tingting Jiang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
Studies of the DMP1 57-kDa Functional Domain both in vivo and in vitro
Yongbo Lu, Chunlin Qin, Yixia Xie, et al.
Cells Tissues Organs (2008) Vol. 189, Iss. 1-4, pp. 175-185
Open Access | Times Cited: 54
Serial Low Doses of Sorafenib Enhance Therapeutic Efficacy of Adoptive T Cell Therapy in a Murine Model by Improving Tumor Microenvironment
Hui-Yen Chuang, Ya-Fang Chang, Ren-Shyan Liu, et al.
PLoS ONE (2014) Vol. 9, Iss. 10, pp. e109992-e109992
Open Access | Times Cited: 37
Management of adverse events during treatment of gastrointestinal cancers with epidermal growth factor inhibitors
Ralf‐Dieter Hofheinz, Siegfried Segaert, María José Safont, et al.
Critical Reviews in Oncology/Hematology (2017) Vol. 114, pp. 102-113
Open Access | Times Cited: 36
Silkworm Pupa Protein Hydrolysate Induces Mitochondria-Dependent Apoptosis and S Phase Cell Cycle Arrest in Human Gastric Cancer SGC-7901 Cells
Xiaotong Li, Hongqing Xie, Yajie Chen, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 4, pp. 1013-1013
Open Access | Times Cited: 35
Nano-liposomal zein hydrolysate for improved apoptotic activity and therapeutic index in lung cancer treatment
Sahand Mazloum-Ravasan, Maryam Mohammadi, Elaheh Madadi Hiagh, et al.
Drug Delivery (2022) Vol. 29, Iss. 1, pp. 1049-1059
Open Access | Times Cited: 17
[EGFR-TKI ADR Management Chinese Expert Consensus].
Chinese Anti-Cancer Association Chinese Society of Lung Cancer
DOAJ (DOAJ: Directory of Open Access Journals) (2019) Vol. 22, Iss. 2, pp. 57-81
Closed Access | Times Cited: 24
Evolutionary karyotypic theory of cancer versus conventional cancer gene mutation theory
Aleksei A. Stepanenko, V. M. Kavsan
Biopolymers and Cell (2012) Vol. 28, Iss. 4, pp. 267-280
Open Access | Times Cited: 26
No human virus sequences detected by next‐generation sequencing in benign verrucous skin tumors occurring in BRAF‐inhibitor‐treated patients
Tina Ganzenmueller, Elias Hage, Yuri Yakushko, et al.
Experimental Dermatology (2013) Vol. 22, Iss. 11, pp. 725-729
Closed Access | Times Cited: 25
Meta‐Analysis of the Risk of Immune‐Related Adverse Events With Anticytotoxic T‐Lymphocyte‐Associated Antigen 4 and Antiprogrammed Death 1 Therapies
Yuga Komaki, Fukiko Komaki, Akihiro Yamada, et al.
Clinical Pharmacology & Therapeutics (2017) Vol. 103, Iss. 2, pp. 318-331
Closed Access | Times Cited: 24
Cutaneous leukocytoclastic vasculitis due to erlotinib: just an adverse event or also a putative marker of drug efficacy?
Giovanni Brandi, Michela Venturi, Emi Dika, et al.
Cutaneous and Ocular Toxicology (2013) Vol. 32, Iss. 4, pp. 336-338
Closed Access | Times Cited: 15
Barrier protective use of skin care to prevent chemotherapy-induced cutaneous symptoms and to maintain quality of life in patients with breast cancer
Johannes Wohlrab, Nikola Bangemann, Anke Kleine-Tebbe, et al.
Breast Cancer Targets and Therapy (2014), pp. 115-115
Open Access | Times Cited: 14
Experiences and coping strategies of oncology patients undergoing oral chemotherapy: First steps of a grounded theory study
Catherine Gassmann, Nina Kolbe, Andrea Brenner
European Journal of Oncology Nursing (2016) Vol. 23, pp. 106-114
Closed Access | Times Cited: 14
Atraumatic tooth extraction in patients taking bisphosphonates: a review of literature and experience with three cases
Sebastian Hoefert, Martin Grimm, Feraydoon Sharghi, et al.
Oral and Maxillofacial Surgery (2014) Vol. 18, Iss. 3, pp. 341-349
Closed Access | Times Cited: 13
Contact dermatitis: relevant differential diagnoses, simulators, and variants
Birger Kränke, Christian Schuster
JDDG Journal der Deutschen Dermatologischen Gesellschaft (2015) Vol. 13, Iss. 11, pp. 1073-1089
Open Access | Times Cited: 13
Low‐concentration vemurafenib induces the proliferation and invasion of human HaCaT keratinocytes through mitogen‐activated protein kinase pathway activation
Mi Ryung Roh, Jeong‐Ki Min, Sang Eun Lee, et al.
The Journal of Dermatology (2015) Vol. 42, Iss. 9, pp. 881-888
Closed Access | Times Cited: 11
Ipilimumab may increase the severity of cutenaous toxicity related to radiotherapy
Melek Karakurt Eryılmaz, Hasan Mutlu, Derya Kıvrak Salim, et al.
Journal of Oncology Pharmacy Practice (2015) Vol. 22, Iss. 3, pp. 533-536
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top